Athlete’s Foot Drugs Market Sluggish Growth Rate Foreseen by 2022-2028
The global athlete’s foot drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The athlete's foot also known as tinea pedis is a fungal skin infection. It usually begins between the toes and occurs in people whose feet have become very sweaty while confined within tight-fitting shoes. The athlete's foot drug is used to treat fungal infection of the feet that causes the scaling and blistering of the soles, fissures at toes as well as painful and burning sensations along itching rashes. The major factor for the growth of the market is the increasing prevalence and rise in incidence rates of athlete’s foot globally.
According to the National
Center for Biotechnology Information (NCBI), an athlete's foot is very common
with an affection rate of an estimated 3 to 15% of the population.
Additionally, as per the same source, men and older people are more likely to
get it. Hence, the increasing prevalence of this infection is driving the
growth of the global athlete’s foot drugs market during the forecast period.
Furthermore, the market is propelling owing to the easy availability of
over-the-counter (OTC) treatment coupled with the low cost of treatment.
To Request a Sample of our Report on Athlete’s Foot Drugs Market: https://www.omrglobal.com/request-sample/athletes-foot-drugs-market
Some major players in the global athlete’s foot drugs
market include Mylan N.V., Novartis International AG, and Pfizer Inc., among
others. The market players are contributing significantly to the growth of the
market by the adoption of various strategies including mergers &
acquisitions, geographical expansion, partnerships and collaborations, and new
product launches, to stay competitive in the market. For instance, in April
2021, Pfizer Inc. acquired Amplyx Pharmaceuticals. The acquisition was aimed to
develop a new treatment for drug-resistant "superbug" for antifungal
treatment.
Market Coverage
• The market number available for –
2020-2027
• Base year- 2020
• Forecast period- 2022-2028
• Segment Covered-
·
By Type
·
By Treatment
• Regions
Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
•
Competitive Landscape- Mylan N.V.,
Novartis International AG, and Pfizer Inc., among others.
A
full Report of Athlete’s Foot Drugs Market is Available @ https://www.omrglobal.com/industry-reports/athletes-foot-drugs-market
Global Athlete’s Foot Drugs Market Report by
Segment
By Type
• Interdigital
• Mocassin
• Vesicular
By Treatment
• Topical
• Oral Antifungal Medication
• Topical Oral Steroid
• Oral Antibiotics
Global Athlete’s Foot Drugs Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment